Coley Pharmaceutical Group, Inc. COLY

Coley Pharmaceutical Group, Inc. 20 William Street, Suite 115 Wellesley, MA 02181
Locations Update This Record Cases by Outcome Cases by Type	SEC CIK 1319197

Add a document

Description
Summary
Document Type	Academic Paper Corporate Document - Internal Corporate Document - Public Court Document Equity Research Government Document - Federal Government Document - State Government Document - Local FBI File Public Records Request Response - FOIA Public Records Request Response - State Non-Profit Report Police Report White Paper
Document Date
Document Source
Source URL
File
	If you would like to be credited for contributing this document, make sure to sign in or sign up first. Once uploaded, your document may not be immediately visible to the public as we review each document for legal issues. Thanks for your patience!

Go Pro to view an analysis and graphs of case roles, types and more.

Filter By From To

	Date Filed	Venue	Case Number	Title	Party Type
	12/4/2007	USPTO Trademark Trial and Appeal Board	78495990-EXT	The Proimmune Company, L.l.c. v. Coley Pharmaceutical Group,...	Potential Opposer
	11/24/2004	USPTO Trademark Trial and Appeal Board	91163170-OPP	Biomune Co. v. Coley Pharmaceutical Group, Inc.	Defendant
	10/12/2004	USPTO Trademark Trial and Appeal Board	78334954-EXT	Biomune Co. v. Coley Pharmaceutical Group, Inc.	Defendant

3 Rows Total

Inside Counsel (0)

Go Pro to view corporate inside counsel.

Outside Counsel (16)

	Last Name	First Name	Middle Name	Firm	Location
	A.	Ph.d	Maria	Wolf, Greenfield & Sacks, PC	BOSTON, MA
	C.	Ph.d	Helen	Wolf, Greenfield & Sacks, PC	Boston, MA
	EL-HAYEK	ROQUE			Boston, MA
	GATES	EDWARD		Wolf, Greenfield & Sacks, PC	Boston, MA
	Gates	Edward	R.		Boston, MA
	Knott	Gail		OFFICE OF RESEARCH & DEVELOPMENT	Baltimore, MD
	Lockhardt	Helen	C.	Wolf, Greenfield & Sacks, PC
	Lockhart	Helen		Wolf, Greenfield & Sacks, PC	Boston, MA
	Lockhart	Helen	C.		BOSTON, MA
	Martin	Lisa		Direct: 617-646-8265	Boston, MA
	Placeholder	TTAB	Attorney	Direct: 617-646-8265	Hamilton, Ontario L8p4z5, MA
	Plaza	Federal	Reseve	Wolf, Greenfield & Sacks, PC	Boston, MA
	R.h.	Waller	Patrick		Boston, MA
	Sacks	Wolf	Greenfield		Boston, MA
	Smith	Chalin			ALEXANDRIA, VA
	Trevisan	Maria		Wolf, Greenfield & Sacks, PC	Boston, MA

16 Rows Total

Filter By Form All Records 10-K 10-K/A 10-Q 15-12G 25-NSE 3 3/A 4 424B4 8-A12B 8-A12G 8-K 8-K/A CORRESP DEF 14A REGDEX S-1 S-1/A S-8 SC 13D SC 13D/A SC 13G SC 13G/A SC 14D9 SC TO-C SC TO-T SC TO-T/A SC14D9C UPLOAD From To

	Date	Entity	Form Number	Description
	2/13/2008		SC 13G/A
	2/13/2008		SC 13G/A
	2/6/2008		SC 13G/A
	1/31/2008	Bate Kenneth	4	Statement of changes in beneficial ownership of securities
	1/25/2008	Krieg, Arthur M.	4	Statement of changes in beneficial ownership of securities
	1/25/2008	Abdalian Charles H Jr	4	Statement of changes in beneficial ownership of securities
	1/25/2008	Massari Ferdinand E	4	Statement of changes in beneficial ownership of securities
	1/25/2008	Bratzler, Robert L.	4	Statement of changes in beneficial ownership of securities
	1/25/2008	Hugin, Robert J.	4	Statement of changes in beneficial ownership of securities
	1/25/2008	Langlois, Patrick	4	Statement of changes in beneficial ownership of securities
	1/25/2008	Karobath Manfred E	4	Statement of changes in beneficial ownership of securities
	1/4/2008		SC 13D
	1/4/2008		8-K	Current report pursuant to Section 13 or 15(d)
	1/4/2008	Pfizer, Inc.	3	Initial statement of beneficial ownership of securities
	1/4/2008		25-NSE
	1/4/2008		15-12G
	1/3/2008		SC 13D/A
	12/31/2007		SC TO-T/A
	12/21/2007		SC 13D
	12/18/2007		SC TO-T/A
	12/14/2007	Karobath Manfred E	4	Statement of changes in beneficial ownership of securities
	11/30/2007		SC TO-T
	11/30/2007		SC 14D9
	11/28/2007		SC14D9C
	11/20/2007		8-K/A
	11/19/2007		SC 13G/A
	11/16/2007		SC14D9C
	11/16/2007		SC14D9C
	11/16/2007		SC TO-C
	11/16/2007		8-K	Current report pursuant to Section 13 or 15(d)
	11/2/2007		10-Q
	11/1/2007		8-K	Current report pursuant to Section 13 or 15(d)
	10/9/2007		8-K	Current report pursuant to Section 13 or 15(d)
	10/9/2007		8-A12B
	9/20/2007	Abdalian Charles H Jr	4	Statement of changes in beneficial ownership of securities
	9/20/2007	Bratzler, Robert L.	4	Statement of changes in beneficial ownership of securities
	9/20/2007	Massari Ferdinand E	4	Statement of changes in beneficial ownership of securities
	9/20/2007	Krieg, Arthur M.	4	Statement of changes in beneficial ownership of securities
	9/7/2007		S-8
	8/29/2007	Krieg, Arthur M.	4	Statement of changes in beneficial ownership of securities
	8/8/2007		10-Q
	8/2/2007		8-K	Current report pursuant to Section 13 or 15(d)
	7/20/2007		SC 13G
	6/29/2007		8-K	Current report pursuant to Section 13 or 15(d)
	6/22/2007		8-K	Current report pursuant to Section 13 or 15(d)
	6/15/2007		8-K	Current report pursuant to Section 13 or 15(d)
	6/15/2007	Bate Kenneth	4	Statement of changes in beneficial ownership of securities
	6/15/2007	Hugin, Robert J.	4	Statement of changes in beneficial ownership of securities
	6/15/2007	Langlois, Patrick	4	Statement of changes in beneficial ownership of securities
	6/15/2007	Karobath Manfred E	4	Statement of changes in beneficial ownership of securities

175 Rows Total	Page 1 of 4 | Go To

	Date Recorded	Party	Role	Document Type	Document No.	Invention Title
	6/19/2014	Pfizer Animal Health S.a.	Assignee	Application Publication	13699997 20130084306	Vaccines Comprising Cholesterol And Cpg As Sole Adjuvant-carrier Molecul... Vaccines Comprising Cholesterol And Cpg As Sole Adjuvant-carrier Molecul...
	6/19/2014	Pfizer Animal Health S.a.	Assignee	Application Publication Patent	13699997 20130084306 10456463	Vaccines Comprising Cholesterol And Cpg As Sole Adjuvant-carrier Molecul... Vaccines Comprising Cholesterol And Cpg As Sole Adjuvant-carrier Molecul... Vaccines Comprising Cholesterol And Cpg As Sole Adjuvant-carrier Molecul...
	3/20/2014	Krieg, Arthur M.	Assignor	Application Publication	12946379 20110244025	Modified Oligoribonucleotide Analogs With Enhanced Immunostimulatory Act... Modified Oligoribonucleotide Analogs With Enhanced Immunostimulatory Act...
	3/20/2014	Lipford, Grayson B.	Assignor	Application Publication	12946379 20110244025	Modified Oligoribonucleotide Analogs With Enhanced Immunostimulatory Act... Modified Oligoribonucleotide Analogs With Enhanced Immunostimulatory Act...
	5/29/2013	Pfizer Animal Health S.a.	Assignee	Application Application Application Application Application Application Application Application Publication Publication Publication Publication Publication Publication Publication Publication Patent Patent Patent Patent Patent Patent Patent	12670697 13360894 10407952 11603978 13046871 13494216 11368333 12946379 20070142315 20110206719 20120258140 20060172966 20110244025 20100272785 20120121648 20030232074 8466124 8658607 8128944 8227447 8153141 7662949 8354522	Immunostimulatory G, U-containing oligoribonucleotides Rna Sequence Motifs In The Context Of Defined Internucleotide Linkages I... Rna Sequence Motifs In The Context Of Defined Internucleotide Linkages I... Modified Oligoribonucleotide Analogs With Enhanced Immunostimulatory Act... Immunostimulatory Oligoribonucleotides Immunostimulatory G, U-containing oligoribonucleotides Immunostimulatory Oligoribonucleotides Rna Sequence Motifs In The Context Of Defined Internucleotide Linkages I... Immunostimulatory G, U-containing Oligoribonucleotides Rna Sequence Motifs In The Context Of Defined Internucleotide Linkages I... Rna Sequence Motifs In The Context Of Defined Internucleotide Linkages I... Modified Oligoribonucleotide Analogs With Enhanced Immunostimulatory Act... Immunostimulatory G, U-containing oligoribonucleotides Immunostimulatory Oligoribonucleotides Rna Sequence Motifs In The Context Of Defined Internucleotide Linkages I... Immunostimulatory Oligoribonucleotides Immunostimulatory G, U-containing oligoribonucleotides Rna Sequence Motifs In The Context Of Defined Internucleotide Linkages I... Rna Sequence Motifs In The Context Of Defined Internucleotide Linkages I... Immunostimulatory G, U-containing Oligoribonucleotides Immunostimulatory Oligoribonucleotides Rna Sequence Motifs In The Context Of Defined Internucleotide Linkages I... Immunostimulatory Oligoribonucleotides
	3/20/2013	Uhlmann, Eugen	Assignor	Application Publication Patent	13690791 20130164333 9156875	Immune Stimulatory Oligoribonucleotide Analogs Containing Modified Oligo... Immune Stimulatory Oligoribonucleotide Analogs Containing Modified Oligo... Immune Stimulatory Oligoribonucleotide Analogs Containing Modified Oligo...
	3/20/2013	Debelak, Harald	Assignor	Application Publication Patent	13690791 20130164333 9156875	Immune Stimulatory Oligoribonucleotide Analogs Containing Modified Oligo... Immune Stimulatory Oligoribonucleotide Analogs Containing Modified Oligo... Immune Stimulatory Oligoribonucleotide Analogs Containing Modified Oligo...
	3/20/2013	Uhlmann, Eugen	Assignee	Application Publication Patent	13609791 20140069094 9121304	Outer Race Locating Washer Outer Race Locating Washer Outer Race Locating Washer
	3/20/2013	Uhlmann, Eugen	Assignee	Application Publication Patent	13690791 20130164333 9156875	Immune Stimulatory Oligoribonucleotide Analogs Containing Modified Oligo... Immune Stimulatory Oligoribonucleotide Analogs Containing Modified Oligo... Immune Stimulatory Oligoribonucleotide Analogs Containing Modified Oligo...
	11/30/2012	Debelak, Harald	Assignor	Application Publication Patent	13690791 20130164333 9156875	Immune Stimulatory Oligoribonucleotide Analogs Containing Modified Oligo... Immune Stimulatory Oligoribonucleotide Analogs Containing Modified Oligo... Immune Stimulatory Oligoribonucleotide Analogs Containing Modified Oligo...
	11/30/2012	Ullman, Eugen	Assignor	Application Publication Patent	13690791 20130164333 9156875	Immune Stimulatory Oligoribonucleotide Analogs Containing Modified Oligo... Immune Stimulatory Oligoribonucleotide Analogs Containing Modified Oligo... Immune Stimulatory Oligoribonucleotide Analogs Containing Modified Oligo...
	11/30/2012	Ullman, Eugen	Assignee	Application Publication Patent	13690791 20130164333 9156875	Immune Stimulatory Oligoribonucleotide Analogs Containing Modified Oligo... Immune Stimulatory Oligoribonucleotide Analogs Containing Modified Oligo... Immune Stimulatory Oligoribonucleotide Analogs Containing Modified Oligo...
	9/7/2011	Uhlmann, Eugen	Assignee	Application Publication	11706561 20080045473	Compositions and methods for oligonucleotide formulations Compositions and methods for oligonucleotide formulations
	9/7/2011	Vollmer, Jorg	Assignee	Application Publication	11706561 20080045473	Compositions and methods for oligonucleotide formulations Compositions and methods for oligonucleotide formulations
	8/11/2011	3m Innovative Properties Company	Assignee	Application Application Application Application Application Application Application Application Application Application Application Application Application Application Publication Publication Publication Publication Publication Publication Publication Publication Publication Publication Publication Patent Patent ...and 14 more	10456308 10165229 10670957 10916125 10933658 11459489 11275553 10595058 10165453 10165002 10013060 10011921 10013202 10012599 20060111387 20080114019 20030158192 20030065005 20030212091 20020193396 20040010007 20040132766 20050032830 20050054640 20060252792 6545017 6525064 ...and 14 more	Sulfonamido Ether Substituted Imidazoquinolines Ether Substituted Imidazopyridines Aryl Ether Substituted Imidazoquinolines 1-amino 1h-imidazoquinolines Heterocyclic Ether Substituted Imidazoquinolines Ether Substituted Imidazopyridines Urea Substituted Imidazoquinoline Ethers 1h-imidazo Dimers Hydroxylamine Substituted Imidazoquinolines Amide Substituted Imidazopyridines Ether Substituted Imidazopyridines Aryl Substituted Imidazoquinolines Sulfonamido Substituted Imidazopyridines Sulfonamido Ether Substituted Imidazoquinolines Ether Substituted Imidazopyridines Aryl Ether Substituted Imidazoquinolines 1-amino 1h-imidazoquinolines Heterocyclic Ether Substituted Imidazoquinolines Ether Substituted Imidazopyridines Urea Substituted Imidazoquinoline Ethers 1h-imidazo Dimers Urea Substituted Imidazopyridines Ether Substituted Imidazopyridines Hydroxylamine Substituted Imidazoquinolines Sulfonamido Substituted Imidazopyridines Sulfonamido Ether Substituted Imidazoquinolines Aryl Substituted Imidazoquinolines ...and 14 more
	4/25/2011	3m Innovative Properties Company	Assignee	Application Publication Patent	10739787 20040147543 7091214	Aryl Substituted Imidazoquinolines Aryl Substituted Imidazoquinolines Aryl Substituted Imidazoquinolines
	4/22/2011	3m Innovative Properties Company	Assignee	Application Application Publication Publication Patent Patent	10696477 11132537 20040097736 20050209267 6949649 7288550	Thioether Substituted Imidazoquinolines Thioether Substituted Imidazoquinolines Thioether Substituted Imidazoquinolines Thioether Substituted Imidazoquinolines Thioether Substituted Imidazoquinolines Thioether Substituted Imidazoquinolines
	4/22/2011	3m Innovative Properties Company	Assignee	Application Application Application Application Application Application Application Application Application Application Application Application Application Application Application Application Application Application Application Application Publication Publication Publication Publication Publication Publication Publication ...and 32 more	10166321 10734306 09820420 10696684 10011670 10669051 10013059 10826836 10165449 11068207 11101369 10165222 09589216 11133425 10425054 10848893 11097715 09589580 10027218 10027272 20020173655 20040204438 20050143413 20030187016 20050197358 20030100764 20050209268 ...and 32 more	Sulfonamide And Sulfamide Substituted Imidazoquinolines Sulfonamide And Sulfamide Substituted Imidazoquinolines Amide Substituted Imidazoquinolines Amido Ether Substituted Imidazoquinolines Amide Substituted Imidazoquinolines Thioether Substituted Imidazoquinolines Thioether Substituted Imidazoquinolines Amide Substituted Imidazoquinolines Thioether Substituted Imidazoquinolines Method For The Treatment Of Dermal Lesions Caused By Envenomation Sulfonamide And Sulfamide Substituted Imidazoquinolines Amido Ether Substituted Imidazoquinolines Sulfonamide And Sulfamide Substituted Imidazoquinolines Amido Ether Substituted Imidazoquinolines Sulfonamide And Sulfamide Substituted Imidazoquinolines And Methods For ... Sulfonamide Substituted Imidazoquinolines Thioether Substituted Imidazoquinolines Sulfonamide And Sulfamide Substituted Imidazoquinolines Sulfonamide And Sulfamide Substituted Imidazoquinolines Pyrazolopyridines And Analogs Thereof Amido Ether Substituted Imidazoquinolines Amide Substituted Imidazoquinolines Thioether Substituted Imidazoquinolines Amide Substituted Imidazoquinolines Amide Substituted Imidazoquinolines Sulfonamide And Sulfamide Substituted Imidazoquinolines Method For The Treatment Of Dermal Lesions Caused By Envenomation ...and 32 more
	3/28/2011	Bratzler, Robert L.	Assignor	Application Publication	12835000 20110033421	Methods Related To Immunostimulatory Nucleic Acid-induced Interferon Methods Related To Immunostimulatory Nucleic Acid-induced Interferon
	3/22/2011	3m Innovative Properties Company	Assignee	Application Application Publication Publication Patent	11884060 12165014 20100240693 20090023722 8378102	Amide Substituted Imidazoquinolines Oxime And Hydroxylamine Substituted Thiazolo [4,5-c] Ring Compounds And ... Oxime And Hydroxylamine Substituted Thiazolo [4,5-c] Ring Compounds And ... Amide Substituted Imidazoquinolines Oxime And Hydroxylamine Substituted Thiazolo [4,5-c] Ring Compounds And ...
	2/22/2011	3m Innovative Properties Company	Assignee	Application Application Application Application Application Application Application Application Application Application Application Application Application Application Application Application Application Application Application Application Application Application Application Application Publication Publication Publication ...and 43 more	10596890 11813052 10596897 11883665 10599159 11884052 11570611 11570704 11887524 11570709 11991686 11884186 11884191 10595065 11884982 11722585 10595230 10595790 11885005 10595895 11885006 10595959 11887496 10596117 20070259907 20090176821 20090005371 ...and 43 more	Pyrazolopyridine-1,4-diamines And Analogs Thereof Sulfone Substituted Imidazo Ring Ethers Aryloxy And Arylalkyleneoxy Substituted Thiazoloquinolines And Thiazolon... Substituted Fused [1,2]imidazo[4,5-c] Ring Compounds And Methods Pyrazolopyridines and Analogs Thereof Substituted imidazo ring systems and methods Nitrogen-containing Heterocyclyl Substituted Imidazoquinolines And Imida... Alkyloxy Substituted Thiazoloquinolines and Thiazolonaphthyridines Hydroxyalkyl Substituted Imidazoquinoline Compounds And Methods Hydroxylamine and oxime substituted imidazoquinolines, imidazopyridines,... Amide Substituted Imidazopyridines, Imidazoquinolines, And Imidazonaphth... Aqueous Gel Formulations Containing Immune Response Modifiers Hydroxyalkyl Substituted Imidazoquinolines Hydroxylamine Substituted Imidazoquinolines Imidazoquinolinyl Sulfonamides Substituted Chiral Fused [1,2]imidazo[4,5-c] Ring Compounds Amide And Carbamate Derivatives Of Alkyl Substituted N-[4-(4-amino-1h-im... Alkoxy substituted imidazoquinolines Arylalkenyl And Arylalkynyl Substituted Imidazoquinolines Multi-Route Administration Of Immune Response Modifier Compounds Method of Preferentially Inducing the Biosynthesis of Interferon Pyrazolopyridine-1,4-diamines And Analogs Thereof Oxime substituted imidazo-containing Compounds Sulfone Substituted Imidazo Ring Ethers Aryloxy And Arylalkyleneoxy Substituted Thiazoloquinolines And Thiazolon... Substituted Imidazoquinolines and Imidazonaphthyridines Pyrazolopyridines and Analogs Thereof ...and 43 more
	1/12/2011	3m Company	Assignor	Application Patent	08092014 5352784	Fused Cycloalkylimidazopyridines Fused Cycloalkylimidazopyridines
	12/9/2010	3m Innovative Properties Company	Assignee	Application Application Application Application Application Application Application Application Publication Publication Publication Publication Publication Publication Publication Publication Patent Patent Patent Patent Patent	11827648 11887525 11991663 10595049 11570567 11570716 12894032 11722288 20070292456 20080015184 20070287725 20110021554 20080207674 20080070907 20110269965 20100317684 7915281 7906506 8168802 8476292 8221771	Amide and Carbamate Derivatives of N-{2-[4-Amino-2- (Ethoxymethyl)-1H-Im... Ring Closing And Related Methods And Intermediates Substituted Chiral Fused [1,2] Imidazo [4,5-c] Ring Compounds And Method... Immune Response Modifier Formulations And Methods Immune Response Modifier Formulations And Methods Isoxazole, Dihydroisoxazole, And Oxadiazole Substituted Imidazo Ring Com... Formulations Containing An Immune Response Modifier Amide And Carbamate Derivatives Of N-{2-[4-amino-2- (ethoxymethyl)-1h-im... Ring Closing And Related Methods And Intermediates Substituted Chiral Fused [1,2] Imidazo [4,5-c] Ring Compounds And Method... Immune Response Modifier Formulations And Methods Immune Response Modifier Formulations And Methods Isoxazole, Dihydroisoxazole, And Oxadiazole Substituted Imidazo Ring Com... Urea Substituted Imidazopyridines, Imidazoquinolines, and Imidazonaphthy... Formulations Containing An Immune Response Modifier Amide and Carbamate Derivatives of N-{2-[4-Amino-2- (Ethoxymethyl)-1H-Im... Ring Closing And Related Methods And Intermediates Substituted Chiral Fused [1,2] Imidazo [4,5-c] Ring Compounds And Method... Isoxazole, Dihydroisoxazole, And Oxadiazole Substituted Imidazo Ring Com... Urea Substituted Imidazopyridines, Imidazoquinolines, and Imidazonaphthy... Formulations Containing An Immune Response Modifier
	11/17/2010	Coley Pharmaceutical Group, Ltd.	Assignor	Application Publication	12946806 20110135605	Methods And Products Related To Treatment And Prevention Of Hepatitis C ... Methods And Products Related To Treatment And Prevention Of Hepatitis C ...
	11/3/2010	3m Innovative Properties Company	Assignee	Application Application Application Application Application Application Application Publication Publication Publication Publication Publication Publication Publication Patent Patent Patent Patent Patent Patent Patent	10595103 10595792 10596895 11570703 11813039 12480471 12173719 20090018122 20090042925 20070167476 20070219228 20080269192 20090318435 20090017076 7897767 7888349 7897609 7943609 7879849 7923429 7897597	Aryloxy And Arylalkyleneoxy Substituted Imidazoquinolines Treatment For Cd5+ B Cell Lymphoma Pyrazolopyridines And Analogs Thereof Chiral Fused [1,2]imidazo[4,5-c] Ring Compounds Aryl Substituted Imidazonaphthyridines Piperazine, [1,4]diazepane, [1,4]diazocane, And [1,5]diazocane Fused Imi... Oxime Substituted Imidazoquinolines Treatment For Cd5+ B Cell Lymphoma Aryloxy And Arylalkyleneoxy Substituted Imidazoquinolines Pyrazolopyridines And Analogs Thereof Chiral Fused [1,2]imidazo[4,5-c] Ring Compounds Aryl Substituted Imidazonaphthyridines Piperazine, [1,4]diazepane, [1,4]diazocane, And [1,5]diazocane Fused Imi... Oxime Substituted Imidazoquinolines Treatment For Cd5+ B Cell Lymphoma Aryloxy And Arylalkyleneoxy Substituted Imidazoquinolines Pyrazolopyridines And Analogs Thereof Chiral Fused [1,2]imidazo[4,5-c] Ring Compounds Aryl Substituted Imidazonaphthyridines Piperazine, [1,4]diazepane, [1,4]diazocane, And [1,5]diazocane Fused Imi... Oxime Substituted Imidazoquinolines
	10/5/2010	3m Innovative Properties Company	Assignor	Application Publication Patent	12480471 20090318435 7879849	Pyrazolopyridines And Analogs Thereof Pyrazolopyridines And Analogs Thereof Pyrazolopyridines And Analogs Thereof
	9/7/2010	Coley Pharmaceutical Group, Ltd.	Assignor	Application Application Application Application Application Application Application Application Publication Publication Publication Publication Publication Publication Publication Publication Patent	12148275 10532746 11183253 11183187 12443224 10816220 11184065 12196201 20100189772 20040235770 20070129320 20090155307 20090017021 20060246035 20060003962 20060287263 7998492	Methods and compositions for inducing antigen-specific immune responses Immunostimulatory Nucleic Acid Oil-in-water Formulations And Related Met... Methods and products related to treatment and prevention of hepatitis C ... Methods And Products Related To Treatment And Prevention Of Hepatitis C ... Methods and compositions for inducing innate immune responses Methods and compositions for inducing innate immune responses Immunostimulatory Nucleic Acid Oil-in-water Formulations And Related Met... Immunostimulatory nucleic acid oil-in-water formulations and related met... Methods And Products Related To Treatment And Prevention Of Hepatitis C ... Compositions of TLR ligands and antivirals Methods and compositions for inducing innate immune responses Methods and compositions for inducing antigen-specific immune responses Immunostimulatory nucleic acid oil-in-water formulations and related met... Methods and products related to treatment and prevention of hepatitis C ... Methods And Products Related To Treatment And Prevention Of Hepatitis C ... Compositions of TLR ligands and antivirals Methods and compositions for inducing innate immune responses
	8/12/2010	Bratzler, Robert L.	Assignor	Application Publication	12835000 20110033421	Methods Related To Immunostimulatory Nucleic Acid-induced Interferon Methods Related To Immunostimulatory Nucleic Acid-induced Interferon
	6/18/2010	Cpg Immunopharmaceuticals, Inc.	Assignor	Application Publication Patent	10956494 20050233999 7879810	Immunostimulatory Nucleic Acid Molecules Immunostimulatory Nucleic Acid Molecules Immunostimulatory Nucleic Acid Molecules
	5/19/2010	Heppner, Philip D.	Assignor	Application Application Publication Publication Patent Patent	11884060 11884060 20100240693 20100240693 8378102 8378102	Oxime And Hydroxylamine Substituted Thiazolo [4,5-c] Ring Compounds And ... Oxime And Hydroxylamine Substituted Thiazolo [4,5-c] Ring Compounds And ... Oxime And Hydroxylamine Substituted Thiazolo [4,5-c] Ring Compounds And ... Oxime And Hydroxylamine Substituted Thiazolo [4,5-c] Ring Compounds And ... Oxime And Hydroxylamine Substituted Thiazolo [4,5-c] Ring Compounds And ... Oxime And Hydroxylamine Substituted Thiazolo [4,5-c] Ring Compounds And ...
	5/19/2010	Kshirsagar, Tushar A.	Assignor	Application Application Publication Publication Patent Patent	11884060 11884060 20100240693 20100240693 8378102 8378102	Oxime And Hydroxylamine Substituted Thiazolo [4,5-c] Ring Compounds And ... Oxime And Hydroxylamine Substituted Thiazolo [4,5-c] Ring Compounds And ... Oxime And Hydroxylamine Substituted Thiazolo [4,5-c] Ring Compounds And ... Oxime And Hydroxylamine Substituted Thiazolo [4,5-c] Ring Compounds And ... Oxime And Hydroxylamine Substituted Thiazolo [4,5-c] Ring Compounds And ... Oxime And Hydroxylamine Substituted Thiazolo [4,5-c] Ring Compounds And ...
	5/19/2010	Lundquist, Gregory D., Jr.	Assignor	Application Application Publication Publication Patent Patent	11884060 11884060 20100240693 20100240693 8378102 8378102	Oxime And Hydroxylamine Substituted Thiazolo [4,5-c] Ring Compounds And ... Oxime And Hydroxylamine Substituted Thiazolo [4,5-c] Ring Compounds And ... Oxime And Hydroxylamine Substituted Thiazolo [4,5-c] Ring Compounds And ... Oxime And Hydroxylamine Substituted Thiazolo [4,5-c] Ring Compounds And ... Oxime And Hydroxylamine Substituted Thiazolo [4,5-c] Ring Compounds And ... Oxime And Hydroxylamine Substituted Thiazolo [4,5-c] Ring Compounds And ...
	5/11/2010	Krieg, Arthur M.	Assignor	Application Publication	12600364 20100285041	Class A Oligonucleotides with Immunostimulatory Potency Class A Oligonucleotides with Immunostimulatory Potency
	4/14/2010	Cpg Immunopharmaceuticals, Inc.	Assignor	Application Publication	10435656 20050277604	Immunostimulatory nucleic acid molecules Immunostimulatory nucleic acid molecules
	4/12/2010	University Of Maryland, Baltimore	Assignor	Application Publication	12083993 20090220522	Detoxified Endotoxin Vaccine and Adjuvant and Uses thereof Detoxified Endotoxin Vaccine and Adjuvant and Uses thereof
	4/12/2010	Memorial Hospital Of Rhode Island	Assignor	Application Publication	12083993 20090220522	Detoxified Endotoxin Vaccine and Adjuvant and Uses thereof Detoxified Endotoxin Vaccine and Adjuvant and Uses thereof
	11/13/2009	Cpg Immunopharmaceuticals, Inc.	Assignor	Application Publication Patent	11598207 20080031936 8258106	Immunostimulatory Nucleic Acid Molecules Immunostimulatory Nucleic Acid Molecules Immunostimulatory Nucleic Acid Molecules
	7/8/2009	Krieg, Arthur M.	Assignor	Application Publication Patent	12472335 20090311277 8114419	Nucleic Acid Compositions For Stimulating Immune Responses Nucleic Acid Compositions For Stimulating Immune Responses Nucleic Acid Compositions For Stimulating Immune Responses
	2/20/2009	Krieg, Arthur M.	Assignor	Application Publication Patent	11542845 20070224210 8304396	Immunostimulatory Nucleic Acids Immunostimulatory Nucleic Acids Immunostimulatory Nucleic Acids
	2/9/2009	Krieg, Arthur M.	Assignor	Application Publication Patent	12336986 20090137519 7795235	Semi-soft C-class Immunostimulatory Oligonucleotides Semi-soft C-class Immunostimulatory Oligonucleotides Semi-soft C-class Immunostimulatory Oligonucleotides
	1/26/2009	3m Innovative Properties Company & 3m Co...	Assignor	Application Publication Patent	11991686 20090176821 8188111	Amide And Carbamate Derivatives Of Alkyl Substituted N-[4-(4-amino-1h-im... Amide And Carbamate Derivatives Of Alkyl Substituted N-[4-(4-amino-1h-im... Amide And Carbamate Derivatives Of Alkyl Substituted N-[4-(4-amino-1h-im...
	11/7/2008	3m Innovative Properties Company	Assignor	Application Publication	11574464 20090270443	1-amino Imidazo-containing Compounds And Methods 1-amino Imidazo-containing Compounds And Methods
	10/6/2008	3m Innovative Properties Company & 3m Co...	Assignor	Application Publication Patent	11887525 20110269965 8168802	Ring Closing And Related Methods And Intermediates Ring Closing And Related Methods And Intermediates Ring Closing And Related Methods And Intermediates
	9/26/2008	3m, Company &.	Assignor	Application Publication Patent	11884153 20100069427 7968563	Oxime And Hydroxylamine Substituted Imidazo[4,5-c] Ring Compounds And Me... Oxime And Hydroxylamine Substituted Imidazo[4,5-c] Ring Compounds And Me... Oxime And Hydroxylamine Substituted Imidazo[4,5-c] Ring Compounds And Me...
	9/17/2008	3m Innovative Properties Company & 3m Co...	Assignor	Application Publication	11887496 20090075980	Pyrazolopyridines and Analogs Thereof Pyrazolopyridines and Analogs Thereof
	9/3/2008	3m Innovative Properties Company & 3m Co...	Assignor	Application Publication Patent	11884982 20090030031 8846710	Method of Preferentially Inducing the Biosynthesis of Interferon Method of Preferentially Inducing the Biosynthesis of Interferon Method of Preferentially Inducing the Biosynthesis of Interferon
	6/18/2008	3m, Company &.	Assignor	Application Publication Patent	11884191 20090099161 8658666	Substituted Imidazoquinolines and Imidazonaphthyridines Substituted Imidazoquinolines and Imidazonaphthyridines Substituted Imidazoquinolines and Imidazonaphthyridines
	6/17/2008	3m, Company &.	Assignor	Application Publication Patent	11887524 20090124611 7943610	Pyrazolopyridine-1,4-diamines And Analogs Thereof Pyrazolopyridine-1,4-diamines And Analogs Thereof Pyrazolopyridine-1,4-diamines And Analogs Thereof
	6/17/2008	3m, Company &.	Assignor	Application Publication Patent	11885005 20090029988 8178677	Hydroxyalkyl Substituted Imidazoquinolines Hydroxyalkyl Substituted Imidazoquinolines Hydroxyalkyl Substituted Imidazoquinolines
	5/28/2008	3m Innovative Properties Company & 3m Co...	Assignor	Application Publication Patent	11885006 20090069314 8158794	Hydroxyalkyl Substituted Imidazoquinoline Compounds And Methods Hydroxyalkyl Substituted Imidazoquinoline Compounds And Methods Hydroxyalkyl Substituted Imidazoquinoline Compounds And Methods
	5/23/2008	3m, Company &.	Assignor	Application Publication Patent	11883665 20090163532 9248127	Aqueous Gel Formulations Containing Immune Response Modifiers Aqueous Gel Formulations Containing Immune Response Modifiers Aqueous Gel Formulations Containing Immune Response Modifiers
	5/12/2008	3m, Company &.	Assignor	Application Publication	11884052 20080318998	Alkyloxy Substituted Thiazoloquinolines and Thiazolonaphthyridines Alkyloxy Substituted Thiazoloquinolines and Thiazolonaphthyridines
	5/8/2008	3m, Company &.	Assignor	Application Publication Patent	11884186 20090005371 8093390	Substituted Fused [1,2]imidazo[4,5-c] Ring Compounds And Methods Substituted Fused [1,2]imidazo[4,5-c] Ring Compounds And Methods Substituted Fused [1,2]imidazo[4,5-c] Ring Compounds And Methods
	4/4/2008	Krieg, Arthur M	Assignor	Application Publication	11988396 20090117132	Anti-Ctla-4 Antibody and Cpg-Motif-Containing Synthetic Oligodeoxynucleo... Anti-Ctla-4 Antibody and Cpg-Motif-Containing Synthetic Oligodeoxynucleo...
	3/20/2008	3m, Company &.	Assignor	Application Application Application Publication Publication Publication Patent Patent	11722585 11570704 11570716 20080119508 20070208052 20070287725 8026366 7915281	Isoxazole, Dihydroisoxazole, And Oxadiazole Substituted Imidazo Ring Com... Aryloxy And Arylalkyleneoxy Substituted Thiazoloquinolines And Thiazolon... Isoxazole, Dihydroisoxazole, And Oxadiazole Substituted Imidazo Ring Com... Aryloxy And Arylalkyleneoxy Substituted Thiazoloquinolines And Thiazolon... Multi-Route Administration Of Immune Response Modifier Compounds Isoxazole, Dihydroisoxazole, And Oxadiazole Substituted Imidazo Ring Com... Aryloxy And Arylalkyleneoxy Substituted Thiazoloquinolines And Thiazolon... Multi-Route Administration Of Immune Response Modifier Compounds
	1/9/2008	3m Company	Assignor	Application Application Publication Publication	11570709 11570709 20070259907 20070259907	Aryl and Arylalkylenyl Substituted Thiazoloquinolines and Thiazolonaphth... Aryl and Arylalkylenyl Substituted Thiazoloquinolines and Thiazolonaphth... Aryl and Arylalkylenyl Substituted Thiazoloquinolines and Thiazolonaphth... Aryl and Arylalkylenyl Substituted Thiazoloquinolines and Thiazolonaphth...
	11/15/2007	3m Company, 3m Innovative Properties Com...	Assignor	Application Publication Patent	10436488 20030232852 6743920	Process For Imidazo[4,5-c]pyridin-4-amines Process For Imidazo[4,5-c]pyridin-4-amines Process For Imidazo[4,5-c]pyridin-4-amines

57 Rows Total

Coley Pharmaceutical Group, Inc. has not been involved in any trademark assignment transactions in the PlainSite database.

Corporate Family (24)

Track Corporate Family

• Abdalian Charles H Jr, None
• Bate Kenneth, None
• Bernitz Steven B, None
• Bratzler, Robert L., None
• Caspritz Gert, None
• Evnin Anthony B, None
• Hugin, Robert J., None
• Karobath Manfred E, None
• Krieg, Arthur M., None
• Langlois, Patrick, None
• Massari Ferdinand E, None
• Pfizer, Inc., None
• Thomas, James E., None
• Tmp Associates Lp, None
• TMP Nominee, LLC, None
• TVM IV Management GmbH & Co. KG, None
• TVM Techno Venture Management GmbH, None
• TVM Techno Venture Management No. III Limited Partnership, None
• TVM V Life Science Ventures Management GmbH & Co. KG, None
• Vef Management III LLC, None
• Venrock Associates, None
• Venrock Associates Iii, LP, None
• Venrock Entrepreneurs Fund III Lp, None
• Venrock Management III LLC, None

Subsidiaries

• Thomas, James E.
• Langlois, Patrick
• Bratzler, Robert L.
• Venrock Associates
• Krieg, Arthur M.
• Hugin, Robert J.
• Venrock Associates Iii, LP
• Bate Kenneth
• Tmp Associates Lp
• Venrock Entrepreneurs Fund III Lp
• Evnin Anthony B
• Vef Management III LLC
• Venrock Management III LLC
• Caspritz Gert
• Abdalian Charles H Jr
• Karobath Manfred E
• Bernitz Steven B
• TVM V Life Science Ventures Management GmbH & Co. KG
• TVM Techno Venture Management GmbH
• TVM IV Management GmbH & Co. KG
• TVM Techno Venture Management No. III Limited Partnership
• TMP Nominee, LLC
• Massari Ferdinand E
• Pfizer, Inc.

Sign in to add additional links.

Incoming Payments

This organization has not disclosed any incoming payments from lobbying groups.

Outgoing Payments

This organization has not disclosed any outgoing payments to lobbying groups.